LIMS2
protein-codingLIM zinc finger domain containing 2, the group of LIM zinc finger domain containing
Gene summary
This gene encodes a member of a small family of focal adhesion proteins which interacts with ILK (integrin-linked kinase), a protein which effects protein-protein interactions with the extraceullar matrix. The encoded protein has five LIM domains, each domain forming two zinc fingers, which permit interactions which regulate cell shape and migration. A pseudogene of this gene is located on chromosome 4. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2011]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~43.4 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0015152
Submitter: ClinGen
*LIMS2*, also known as *PINCH2*, was first reported in relation to autosomal recessive limb-girdle muscular dystrophy in 2015 (Chardon JW et al., PMID:25589244). Three missense variants have been reported in a pair of siblings with the limb-girdle phenotype in the literature; this is the only report known to have been published of a *LIMS2* variant identified in a patient with autosomal recessive limb-girdle muscular dystrophy. None of these variants have functional evidence in support of pathogenicity and the mechanism for disease is unknown. ClinVar contains submissions for variants within this gene; the panel contacted submitters of pathogenic and likely pathogenic ClinVar contributions and found no additional evidence to support this gene-disease relationship. The loxP/Cre system was used to knock out *LIMS2* in a mouse model. The resulting *LIMS2* deficient mice showed no apparent phenotype when compared to their wild-type and heterozygous littermates (PMID:16317048). RNA sequencing of total RNA from 20 human tissues shows non-specific expression of *LIMS2* in skeletal muscle, low to moderate in comparison to expression in other tissues (NCBI Bioproject:PRJNA280600). The evidence of this gene-disease relationship is limited to a few cases carrying missense variants and presenting with genetically heterogeneous phenotypes with a sum of genetic evidence below 0. No compelling experimental evidence is available. In summary, the evidence supporting the relationship between *LIMS2* and autosomal recessive limb-girdle muscular dystrophy has been disputed and no valid evidence remains to support the claim. More evidence is needed to either support or entirely refute the role *LIMS2* plays in this disease. This classification was approved by the ClinGen Muscular Dystrophies and Myopathies Gene Curation Expert Panel on the meeting date November 12, 2024 (SOP Version 11).
Inheritance Pattern: Unknown
Disease ID:MONDO:0014788
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0014788
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0014788
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Cardiovascular; Craniofacial; Musculoskeletal
Intervention: Cardiovascular
Rationale: The condition can include dilated cardiomyopathy, and knowledge may allow early diagnosis and medical management
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to LIMS2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001161403.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 53 | 4 | 60 | ||
| missense | 1 | 156 | 4 | 161 | ||
| nonsense | 6 | 6 | ||||
| start loss | 1 | 1 | ||||
| frameshift | 2 | 5 | 7 | |||
| splice donor/acceptor (+/-2bp) | 1 | 12 | 13 | |||
| Total | 1 | 3 | 183 | 57 | 4 | 248 |
Highest pathogenic variant AF is 0.000036563615
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001154875.1 | 10 | MANE Select | |
| Ensembl | ENSP00000347240.4 | 10 | MANE Select | |
| RefSeq | NP_001129509.2 | 11 | Standard | |
| RefSeq | NP_001154876.1 | 9 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| lims2 | Danio rerio | Structure: pericardium Quality: edematous abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Integrin-linked kinase signaling
- Cell-extracellular matrix interactions
- Cell junction organization
- Cell-Cell communication
Biological Process
- cell junction assembly
- negative regulation of apoptotic process
- cell-cell junction organization
- cell-cell adhesion
- negative regulation of neural precursor cell proliferation
Molecular Function
- metal ion binding
Cellular Component
- nucleus
- cytosol
- plasma membrane
- focal adhesion
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000324938
- Coding exons
- 10
- Length
- 43405
- Individuals with no LoFs
- 125683
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 60
- Defined
- 125743
- p
- 0.000239
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.373 | 208 | 224 | 0.930 | 0.0000150 | 2387 |
| Missense (PolyPhen) | 96 | 95.424 | 1.006 | 963 | ||
| Synonymous | 1.15 | 81 | 95.2 | 0.850 | 0.00000701 | 664 |
| Loss of Function | 1.96 | 10 | 19.3 | 0.519 | 8.96e-7 | 235 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00044 | 0.00043 | rare |
| Latino/Admixed American | 0.00026 | 0.00026 | rare |
| Ashkenazi Jewish | 0.000099 | 0.000099 | rare |
| East Asian | 0.00011 | 0.00011 | rare |
| Finnish | 0.000092 | 0.000092 | rare |
| European (Non-Finnish) | 0.00028 | 0.00027 | rare |
| South Asian | 0.00024 | 0.00023 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Adapter protein in a cytoplasmic complex linking beta- integrins to the actin cytoskeleton, bridges the complex to cell surface receptor tyrosine kinases and growth factor receptors. Plays a role in modulating cell spreading and migration. {ECO:0000269|PubMed:12167643}.;
- Disease
- DISEASE: Limb-girdle muscular dystrophy 2W (LGMD2W) [MIM:616827]: A form of autosomal recessive limb-girdle muscular dystrophy, a degenerative myopathy characterized by slowly progressive wasting and weakness of the proximal muscles of arms and legs around the pelvic or shoulder girdles, elevated creatine kinase levels and dystrophic features on muscle biopsy. LGMD2W is characterized by childhood-onset of weakness progressing to a severe quadriparesis. Additionally, patients have biventricular cardiac dysfunction due to dilated cardiomyopathy. {ECO:0000269|PubMed:25589244}. Note=The disease may be caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.117
Intolerance Scores
- LoFtool
- 0.0722
- RVIS EVS
- -0.8
- RVIS percentile EVS
- 12.33
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.598
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |